<DOC>
	<DOCNO>NCT00388596</DOCNO>
	<brief_summary>The first purpose study determine take SB-751689 along Rosuvastatin ( CRESTOR ) Atorvastatin ( LIPITOR ) change Rosuvastatin Atorvastatin absorb eliminate body . Rosuvastatin Atorvastatin prescription medication use treat patient high cholesterol . Patients would take SB-751689 osteoporosis might also take Rosuvastatin Atorvastatin high cholesterol . In early study , SB-751689 show low blood level Rosuvastatin two drug take time . Lower blood level Rosuvastatin could mean would effective lower cholesterol . In study SB-751689 take alone , Rosuvastatin take alone , SB-751689 Rosuvastatin take together , SB-751689 take 12 hour Rosuvastatin take . This study help determine two drug take 12 hour apart prevent low Rosuvastatin blood level . Atorvastatin take alone time SB-751689 determine Atorvastatin blood level low take time SB-751689 . A second purpose study determine take another drug call Ketoconazole ( Nizoral ) along SB-751689 change SB-751689 absorb eliminate body . Ketoconazole prescription medication use treat patient fungal yeast infection .</brief_summary>
	<brief_title>A Study Of SB-751689 , Atorvastatin , Ketoconazole , And Rosuvastatin In Health Postmenopausal Women .</brief_title>
	<detailed_description />
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<mesh_term>Ketoconazole</mesh_term>
	<criteria>Healthy ambulatory postmenopausal woman define amenorrheic least 2 year Nonsmoker Weight &gt; 110 lb ( &gt; 50 kg ) Body mass index within range 19 29.9 kg/m2 capable give write informed consent Have clinically relevant abnormality identify screen history physical laboratory examination , 12lead surface electrocardiogram ( ECG ) and/or 24 hour Holter , include QTc &gt; 450 msec Test positive urine drug screen alcohol Test positive HIV , hepatitis B virus hepatitis C virus Smoker history smoking use nicotine containing product within one year study &gt; 10 packyear history smoke overall history regular alcohol consumption exceed 7 units/week ( 1 unit = 5 ounce wine 12 ounce beer 1.5 ounce hard liquor ) within 6 month screen history drug abuse within 6 month study participate trial investigational drug within 30 day 5 halflives ( whichever longer ) precede first dose study medication use prescription nonprescription drug ( include calcium tablet , calcium contain antacid , aspirin nonsteroidal antiinflammatory drug ) , vitamin , herbal dietary supplement , within 14 day prior first dose study medication . consume grapefruit contain product within 14 day prior first dose study medication donate blood excess 500 mL within 56 day prior dose evidence kidney liver disease history significant gastrointestinal disease gastrointestinal surgical procedure sensitive study medication component thereof history cardiovascular disease medical condition might alter bone metabolism serum parathyroid hormone ( iPTH ) test , vitamin D level outside normal range</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>SB-751689</keyword>
	<keyword>osteoporosis</keyword>
	<keyword>drug interaction</keyword>
	<keyword>ketoconazole</keyword>
	<keyword>atorvastatin</keyword>
	<keyword>rosuvastatin</keyword>
</DOC>